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Abstract 
Cambodia is a country in the Greater Mekong Subregion of Southeast Asia. The Khmer Rouge 
genocide in the mid 1970s produced significant setbacks in the nation’s healthcare system. While 
much progress has been made, rural areas still lack access to medical professionals, facilities, 
and equipment. Three of the most problematic diseases in Cambodia have been malaria, HIV, 
and tuberculosis. Due to the inadequacies of rural healthcare, treatment-resistant varieties of 
malaria and tuberculosis have become a serious concern for both the nation and Southeast Asia 
as a whole. The question of how to best provide aid to these isolated communities is 
characterized by complex and multifaceted discussions that seek to bring Cambodia to a place of 
greater health. 
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Health Concerns in Cambodia Compounded by Historical and Rural Inadequacies 
Introduction 
Encyclopedia Britannica describes the region of Southeast Asia as “a region of Asia 
situated east of the Indian subcontinent and south of China”; it can be divided into two mainland 
and insular portions, which are bridged by the Malay peninsula. Throughout much of history, 
this area was a crucial component of many trading networks and attracted many nations 
(Leinbach & Frederick, 2018). Eventually, Europe’s arrival on the scene completely restructured 
the economy and increased the disparity between the rich and poor (Leinbach & Frederick, 
2018). While some of the SE Asian nations have experienced notably increased development 
since the 1960s, particularly those who became members of the Association of Southeast Asian 
Nations (ASEAN) at the outset of its formation, others have struggled significantly (Leinbach & 
Frederick, 2018). Initially non-ASEAN countries, including Cambodia, Laos, Myanmar, and 
Vietnam, were, and still are, “among the poorest nations in the world” (Leinbach & Frederick, 
2018). 
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Figure 1. Map of Southeast Asia. From “Which Countries Are Considered to Be Southeast 
Asia?”, by V. Kiprop, 2018, https://www.worldatlas.com/articles/which-countries-are-
considered-to-be-southeast-asia.html 
 
Cambodia is bordered by Thailand, Laos, and Vietnam, and its landscape consists 
primarily of plains, low mountains, and the upper part of the Mekong River Delta (Chandler & 
Overton, 2019). The Khmer people comprise 90% of the population; although this does make for 
a fairly homogenous society, they struggle to integrate the Vietnamese, Chinese, Thai, Cham, 
and Lao minorities that make up the much smaller portion (Chandler & Overton, 2019). In its 
early days, Cambodia’s civilization was primarily influenced by India and China (Chandler & 
Overton, 2019). In the 12th century, the Khmer (Cambodian) Empire reached its own golden age 
and constructed the stunningly beautiful Angkor temple complexes (Chandler & Overton, 2019).  
From then on, the country experienced a steady decline as it was colonized by the French 
in 1863 and then occupied by the Japanese in the 20th century (Chandler & Overton, 2019). After 
regaining their independence in 1954, Cambodia began shifting from a monarchy to an 
authoritarian regime (Chandler & Overton, 2019). Following a brief civil war initiated by yet 
another regime change, the country was devastated by the Khmer Rouge, a “rural communist 
guerrilla movement” led by Pol Pot that lasted from 1975 to 1979 (Chandler & Overton, 2019). 
Prime minister Pol pot, also known as Saloth Sar, sought to follow Maoist China and convert the 
nation’s people into a collectivized and unpaid labor force, but ultimately committed genocide in 
the process (Chandler & Overton, 2019). During this reign of terror, “at least 1.5 million 
Cambodians died or were killed” (Chandler & Overton, 2019). Primary causes of death were 
disease, starvation, overwork, and execution often brought on by the party’s rampant paranoia 
(Chandler & Overton, 2019). Additionally, ‘intellectual cleansing occurred’ resulting in the mass 
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murder of educated individuals; “personal and political freedoms were outlawed” (Ozano et al., 
2018).  
Vietnamese intervention deposed the regime and started rebuilding Cambodia, but by 
then, many of the educated elite had fled and sought refuge in other countries (Chandler & 
Overton, 2019). Cambodia finally joined ASEAN in 1999 and the World Trade Organization in 
2004; slowly, the country has been regaining the confidence of its foreign allies (Chandler & 
Overton, 2019). Steps have also been taken to control the AIDS epidemic and reduce the 
‘runaway’ birth rate (Chandler & Overton, 2019). Despite this recent progress, there is still a 
long road of recovery ahead for Cambodia. While the capital of Phnom Penh has become a dense 
city, a 2018 survey reported that only 23.4% of Cambodians live in an urban setting and 76.6% 
of the population lives in rural areas (Chandler & Overton, 2019). These rural areas lack both 
healthcare facilities and healthcare professionals, as well as proper sanitation and clean water 
(McGrew, 1990). This only serves to exacerbate the current situation in which treatment-resistant 
strains of malaria and tuberculosis are sweeping across Southeast Asia (Giffels, 2019). Cambodia 
is not currently equipped to deal with these problems on its own. Foreign aid could prove 
instrumental in coming alongside this nation and its people that are fighting to get back on their 
feet. However, the manner in which the aid is rendered must be carefully evaluated.  
Overview of the Health Care Situation 
 By the end of the Khmer Rouge, Cambodia’s health care system had been severely 
crippled (McGrew, 1990). Major infrastructure was destroyed along with supplies, equipment, 
and personnel (McGrew, 1990). Many of the people killed during the regime were educated 
professionals, and reports say that only 45 doctors survived; of those 45, 20 fled Cambodia 
(McGrew, 1990). By the end of 1979, only 728 medical students remained in the country 
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(McGrew, 1990). The majority of hospitals and medical facilities were also destroyed (“Health 
First…”, 2016).  
 Current Health Care System 
Cambodia’s Ministry of Health “worked with several international development agencies 
to reform the country’s healthcare system” during the 1990s (“Healthcare in Cambodia”, 2017). 
This department has invested in numerous strategies including private insurance, voluntary 
community-based health insurance, and Health Equity Funds (“Healthcare in Cambodia”, 2017). 
The government is investing in both the public and private health sectors, with emphasis on the 
establishment of provincial health departments (“Healthcare in Cambodia”, 2017). Despite these 
efforts, medical professionals are still severely lacking, and as of 2017, there were only 0.7 
hospital beds per 1000 people (“Healthcare in Cambodia”, 2017). Although a concerted effort 
has been made to educate greater numbers of medical professionals, there is still a drastic 
shortage (“Healthcare in Cambodia”, 2017). Currently, the majority of the public health workers 
are hardworking midwives and nurses, but they are unable to meet the extensive needs of the 
nation (“Healthcare in Cambodia”, 2017). Private healthcare has grown significantly and 
dominates the curative care field (“Healthcare in Cambodia”, 2017). Additionally, private 
spending has increased notably as a direct reaction to the inadequacy of public services 
(“Healthcare in Cambodia”, 2017). Over half of Cambodians went to private providers in 2015 
(“Healthcare in Cambodia”, 2017). In light of this rapid growth, the Ministry of Health has now 
turned to the development of more effectual regulations concerning licensing requirements and 
enforcements in the private sector (“Healthcare in Cambodia”, 2017). 
 The Rural Disparity 
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  As previously mentioned, the majority of the Cambodian people live in provincial areas 
far away from structured medical care (McGrew, 1990). This has resulted in significant 
“inequities in health outcomes based on socio-economic status and between rural and urban 
populations” (“Health First…”, 2016). Phnom Penh has the most advanced healthcare facilities 
in the country, along with the greatest concentration of medical professionals; the vast majority 
of rural areas however, lack clean water, sanitation, trained personnel, facilities, and medicine 
(McGrew, 1990). Cambodia’s poor, disabled, and indigenous minorities face overwhelming 
obstacles to obtaining health services (“Health services and centers”, 2016). Various programs 
have been initiated to help provide health care at minimal costs, but access to quality care is still 
limited (“Health services and centers”, 2016).  
Primary Health Concerns for Cambodia and Southeast Asia 
 As a region, Southeast Asia is not only plagued by numerous natural disasters, it is also 
home to a number of emerging and remerging infections (Acuin et al., 2011). There are a number 
of factors that have facilitated this increased risk of emergent diseases (Coker, Hunter, Rudge, 
Liverani, & Hanvoravongchai, 2011). First, this region is home to a large diversity of vector-
borne and zoonotic pathogens; compounding this is the existence of ecological factors that 
promote rapid mutation of the pathogens, along with host adaptation (Coker et al., 2011). 
Additionally, “the high density, proximity, and mobility of human beings and animal reservoirs 
provide fertile conditions for transmission between species, within human populations, and 
across geographic areas” (Coker et al., 2011). Urbanization and the growth of livestock and 
agriculture have ultimately reshaped Southeast Asia (Coker et al., 2011). The varying quality of 
healthcare throughout the nations often exacerbates issues and presents unique challenges to 
controlling the spread of diseases across country borders (Acuin et al., 2011). This problem 
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requires the increased and effective cooperation of global and regional communities (Acuin et 
al., 2011). Oftentimes, irregular migration of peoples in the region can lead to microcosms 
plagued by inadequate medical care and living conditions; such migrants are also particularly 
vulnerable to exploitation (Acuin et al., 2011). 
 Cambodia’s health ‘landscape’ has been shaped and characterized by a number of 
concerns. One of the primary issues has revolved around the maternal mortality rate; thankfully, 
the ratio has fallen from 1,020 in 100,000 births in 1990, to 161 in 2015 (“Priority health 
concerns”, 2017). This was largely due to an increasing number of mothers whose babies were 
delivered by health professionals and in medical facilities (“Priority health concerns”, 2017). 
Moreover, the vast majority attended antenatal care and most HIV+ mothers received 
antiretroviral treatments to prevent viral transmission to their infants (“Priority health concerns”, 
2017). Although progress has been made in this area and mortality rates have dropped, the 
prevalence of child death and the birth of underweight newborns is still high compared to many 
other countries (“Priority health concerns”, 2017). Other notable concerns include Dengue fever, 
along with diarrhea diseases, acute respiratory infections, and malnutrition, all of which 
particularly contribute to the child mortality rate (“Priority health concerns”, 2017). The Asia 
Pacific Journal of Clinical Nutrition reported in 2014 that “malnutrition costs Cambodia more 
than $400 million annually and contributes to the deaths of 6,000 children each year”; 
additionally, UNICEF says that “2,000 Cambodian children die from preventable diarrhea 
diseases annually” (“Priority health concerns”, 2017). 
There are three notable diseases that Cambodia as a whole has especially struggled with, 
namely, malaria, tuberculosis, and HIV (Tomb, 2016). Despite recent advances made in the 
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treatment of these infections, the rural disparity slows progress and acts as a stumbling block to 
the quick responses needed to keep on top of and ultimately eliminate the issues (Tomb, 2016). 
Malaria 
Malaria is caused by the intracellular parasites of the genus Plasmodium, but Plasmodium 
falciparum is the most lethal variety transmitted (Gardner et al., 2002). The most common vector 
that transmits this parasite is the Anopheles (An.) mosquito and 40% of humans live in a region 
where this disease is transmitted (Gardner et al., 2002). In Cambodia the dominant vectors are 
An. dirus and An. minimus (see Figure 2) (Sinka et al., 2012).  
 
 
Figure 2. Geographical distribution of malaria Anopheles vectors in Asia. From “A global map 
of dominant malaria vectors", by M. Sinka et al., 2012,  
https://parasitesandvectors.biomedcentral.com/articles/10.1186/1756-3305-5-69 
 
Plasmodium invades host erythrocytes while in its infective sporozite stage (Mota et al., 2001). 
The sporozite breaches the plasma membrane of one cell, traverses the cytosol, and then exits 
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and invades the next cell (Mota et al., 2001). This occurs several times before the final invasion 
in which a parasitophorous vacuole is formed that facilitates the development of the parasite into 
the next stage (Mota et al., 2001). As the parasite matures, it causes waste and toxic factors to 
accumulate in the red blood cell (“Disease”, 2019). The genome of the Plasmodium parasite 
primarily directs the production of genes dedicated to host-parasite interactions and the evasion 
of the immune system (Gardner et al., 2002). Plasmodium falciparum causes infected 
erythrocytes to attach to the vascular endothelium of the smaller blood vessels in a process called 
cytoadherence (Ho & White, 1999). This prevents detection of the parasite by the spleen and also 
obstructs normal fluid flow through the circulatory system, ultimately compromising the flow of 
oxygen between tissues (Ho & White, 1999). This leads to hypoxia, metabolic disturbances, and 
the failure of multiple organs (Ho & White, 1999). Common symptoms include headaches, fever, 
muscular pain, nausea, and vomiting (“Treatment of Malaria…”, 2019). More serious cases can 
also produce disorientation, coma, and anemia (“Diagnosis and Treatment…”, 2018).  
Malaria is divided into two main varieties described as being either uncomplicated or 
severe (“Diagnosis and Treatment…”, 2018). Severe malaria is most often caused by 
Plasmodium falciparum and requires immediate assessment and treatment (“Diagnosis and 
Treatment…”, 2018). In the developed world, microscopy and laboratory diagnostic tests are 
used to make a definitive diagnosis; blood smears from the patient are viewed under the 
microscope (see Figure 3) and the parasite’s density is estimated if present (“Treatment of 
Malaria…”, 2019). After confirmation of the malaria, appropriate treatment is determined based 
on the “infecting Plasmodium species, the clinical status of the patient, expected drug 
susceptibility of the infecting parasite as determined by the geographic area where the infection 
was acquired, and previous use of antimalarials” (“Treatment of Malaria…”, 2019).  
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Figure 3. Plasmodium falciparum (dark rings) in blood smear. From “Plasmodium falciparum”, 
by H. Fadel, 2014, 
http://www.pathologyoutlines.com/topic/parasitologymalariapfalciparum.html Copyright 2003-
2020 by PathologyOutlines.com, Inc. 
 
The most common antimalarials drugs include artemisinin-based combination therapies (ACTs), 
which are a combination of two or more drugs, and chloroquine phosphate; chloroquine, 
however, is now no longer effective in all parts of the world due to resistance developed by some 
malarial parasites (“Malaria”, 2018).  
The United States Agency for International Development reports that “despite many 
public health advancements in the region, 65 million people in Southeast Asia are at risk of 
malaria infection” (“Malaria: Asia Regional”, 2019). It also stated that, in the Greater Mekong 
Subregion, an estimated 260,000 people are infected with malaria each year; this number is most 
likely higher due to the lack of proper reporting and detection in rural areas that commonly suffer 
from the disease (“Malaria: Asia Regional”, 2019). Symptoms of malaria are generally non-
specific, making it somewhat difficult to diagnose (“Diagnosis and Treatment…”, 2018). 
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Various problems can arise in developing countries when attempting to run diagnostic tests 
(“Diagnosis and Treatment…”, 2018). First, many clinics lack the equipment necessary, 
especially microscopes, to make laboratory diagnoses (“Diagnosis and Treatment…”, 2018). 
Microscopic test results can be affected by the quality of the microscope itself, the quality of the 
reagents used, and the experience of the lab technician (“Diagnosis and Treatment…”, 2018). 
They also often do not possess rapid diagnostic tests (RDTs); RDTs are immunochromatographic 
tests that can detect malarial antigens in the patient’s blood, oftentimes in as little as 20 minutes 
(“Diagnosis and Treatment…”, 2018). Additionally, many of the health personnel in these areas 
are undertrained (“Diagnosis and Treatment…”, 2018). Nonetheless, many countries’ 
community health workers (CHWs) can be and have been trained to use RDTs if they have them 
and are educated on “integrated community case management of common childhood illnesses, 
including malaria” (“Diagnosis and Treatment…”, 2018). 
HIV  
The human immunodeficiency virus (HIV) takes over host cell systems in order to carry 
out self-replication (Monette, Panté, & Mouland, 2011). One mechanism by which HIV-1, the 
most common type of HIV, exerts viral control over the host cell is by interfering with the 
proteins and components embedded in the membrane surrounding the cell’s nucleus (Monette et 
al., 2011). With the alteration of the nucleoporins, the virus blocks nuclear transport and 
interferes with normal homeostatic processes (Short, 2011). This includes enacting extreme 
changes in the host cell nuclear envelope, resulting in the disruption of transport between the 
cytoplasm and nucleus and contributes to the production of viral proteins (Short, 2011). 
Ultimately, HIV attacks the immune system and leaves the individual susceptible to life-
threatening cancers and infections (“HIV Treatment Overview”, 2019). Opportunistic infections 
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are those that would not typically threaten a healthy person, but can occur when an 
immunocompromised individual’s CD4 count falls below a certain level; patients with HIV must 
therefore take appropriate precautions to avoid such infections (“HIV Treatment Overview”, 
2019). 
While no cure currently exists for HIV, certain drugs can be taken in order to slow 
disease progression and lessen its severity (“HIV Treatment: The Basics”, 2019). The primary 
treatment, antiretroviral treatment (ART), combats the virus attacking the immune system and 
reduces the risk of transmittance (“HIV Treatment: The Basics”, 2019). Some side effects do 
exist but differ from person to person; effects include nausea and vomiting, headache, diarrhea, 
rash, fatigue, dry mouth, pain, and insomnia (“HIV Treatment Overview”, 2019). If the patient 
stops treatment, resistance may develop and hinder future treatment attempts (“HIV Treatment 
Overview”, 2019). The virus can mutate on its own as it reproduces and generate variations that 
are no longer responsive to ART (“HIV Treatment Overview”, 2019).  
Cambodia has made significant strides in addressing the HIV/AIDS crisis within its 
borders (Heidt & Emond, 2016). By leaning on the advice of its international partners, the nation 
has been able to greatly reduce the number of new infections and implement antiretroviral 
treatment almost immediately after diagnosis (Heidt & Emond, 2016). Better education has 
reduced the risk of contracting this disease, and it is now not as widespread in the commercial 
sex trade, although this practice contributed greatly to the disease’s initial spread (“Spread of 
HIV Is Slowing…”, 2003). However, many people that are currently infected are still unreached 
and untreated (Heidt & Emond, 2016).  
Tuberculosis  
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Tuberculosis (TB) results from an infection by Mycobacterium tuberculosis (Flynn & 
Chan, 2001). This organism is a slow-growing, acid-fast rod bacterium that is primarily 
transmitted by the respiratory route (Flynn & Chan, 2001). Individuals with laryngeal or 
pulmonary TB transmit the disease via talking, coughing, or sneezing, when airborne droplets are 
expelled into the air and subsequently inhaled by another person (Dye & Floyd, 2006). The 
inhaled bacteria are deposited in the alveoli of the lung, where they are then engulfed by 
macrophages (Dye & Floyd, 2006). Tuberculosis can either actively manifest or remain latent; in 
its latent stage, the bacteria remain dormant for some amount of time before possible reactivation 
(Flynn & Chan, 2001). The infecting bacteria survive within a granuloma composed of 
fibroblasts, macrophages, B cells, and T cells (Flynn & Chan, 2001). While the most common 
manifestation is pulmonary tuberculosis, a number of organs can be targeted (Flynn & Chan, 
2001). Pulmonary varieties typically occur in the parenchyma of the middle and lower lung (Dye 
& Floyd, 2006). Symptoms of active TB in the lung include night sweat, cough with sputum and 
occasional blood, weakness, chest pains, weight loss, and fever (“Tuberculosis”, 2019). The 
disease is especially deadly when contracted in conjunction with HIV (“Tuberculosis”, 2019).  
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Figure 4. Mycobacterium tuberculosis bacilli (pink) in sputum. From “Interrupting Transmission 
of Tuberculosis Key to Containing Global Epidemic”, by J. Oriol, 2017, 
https://www.infectiousdiseaseadvisor.com/home/topics/respiratory/interrupting-transmission-of-
tuberculosis-key-to-containing-global-epidemic/ 
 
Tuberculosis is typically diagnosed through either a sputum, skin, or blood test 
(“Diagnosing and Treating Tuberculosis”, 2018). Sputum samples are viewed by a laboratory 
technician under a microscope (see Figure 4) in order to identify the bacteria (“Tuberculosis”, 
2019). The World Health Organization (WHO) also recommends the rapid test Xpert 
MTB/RIF®, as it “simultaneously detects TB and resistance to rifampicin, the most important 
TB medicine” (“Tuberculosis”, 2019). Treatment differs depending on whether the TB is latent 
or active (“Diagnosing and Treating Tuberculosis”, 2018). If the infection is latent, then the 
measures taken are preventative in nature, and isoniazid (INH) is prescribed (“Diagnosing and 
Treating Tuberculosis”, 2018). In active cases, treatment entails a combination drug therapy; the 
most common drugs used are INH, rifampin, pyrazinamide, and ethambutol (“Diagnosing and 
Treating Tuberculosis”, 2018). Additional strategies are used when TB is detected in an 
individual with HIV. According to the WHO, “people living with HIV are 19 (15-22) times more 
likely to develop active TB disease than people without HIV”; both diseases serve to amplify and 
quicken each other (“Diagnosing and Treating Tuberculosis”, 2018). This phenomenon is of 
particular concern, due to the great prevalence of HIV in Cambodia (Zaman, 2010). 
While tuberculosis is curable, areas with restricted access to healthcare, such as those in 
Cambodia, have greatly struggled in implementing treatment (Zaman, 2010). Poorer areas are 
more at risk for TB, possibly stemming from immune systems weakened by malnourishment and 
increased risk of transmission resulting from a lack of effective ventilation and hygiene (Zaman, 
2010). Southeast Asia is estimated to be carrying one-third of the world’s TB burden, with 
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approximately 4.9 million cases (Nair, Wares, & Sahu, 2010). Also reported by the WHO is that 
“at least one-third of TB patients go undetected or get treated outside national programmes”; 
once again, inadequate facilities, detection equipment, and staffing contribute to the challenges 
hindering proper treatment (Nair et al., 2010). The WHO believes focusing on the 
implementation of DOTS (directly observed treatment, short-course) strategies can help 
overcome some of the constraints (Nair et al., 2010).  
Antimicrobial Resistance as it affects this Region  
Southeast Asia as a region, and specifically Cambodia, has experienced a frightening 
increase in antimicrobial resistance (AMR) over the last decade, and it is recognized as one of 
the most severe threats to global public health (Giffels, 2019). AMR refers to a phenomenon in 
which first-line treatments for a particular disease, in this case malaria and tuberculosis, are 
becoming ineffective on a much larger scale than previously witnessed (Giffels, 2019). While the 
issue partly stems from unavoidable natural occurrences, it has been amplified by human 
activities (“Antibiotic resistance”, 2018). The unregulated sale of antibiotics and the use of 
antibiotics for livestock in addition to human prescription are common problems in Southeast 
Asia (Giffels, 2019). Once again, poverty has exacerbated health concerns due to a lack of 
effective structured health care (Giffels, 2019). Resistant strains are currently spreading, and the 
majority of public health systems across the region are ill-equipped to handle such an issue 
(Giffels, 2019). Growing AMR in malaria and tuberculosis is of particular concern.  
Malaria 
Resistant malaria is characterized by an unresponsiveness to first-line ACT treatment 
(Dondorp et al., 2009). Failure of the ACT combination drugs, dihydroartemisinin and 
piperaquine, was first clinically reported in western Cambodia in 2013, five years after the drugs 
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were first introduced (Dall, 2018). Treatment resistance in Cambodia has increased in frequency 
since then, and now its neighbors, Thailand, Laos, Vietnam, and Mynamar in the Greater 
Mekong Subregion, are experiencing the same phenomenon (Dall, 2018). Research has pointed 
to a particular strain of mutant Plasmodium falciparum as the primary cause behind this 
dihydroartemisinin-piperaquine resistance (Dall, 2018). From 2007 to 2013, the Wellcome 
Sanger Institute conducted a study in which they collected and analyzed the genome sequence 
data of 1,492 P. falciparum samples from 11 locations across Southeast Asia, including 464 
samples retrieved from western Cambodia (Dall, 2018). They found that the majority of the 
samples carried mutations of the kelch13 gene, which resulted in artemisinin resistance; 
resistance to piperaquine was connected to another genetic marker that showed the amplification 
of the plasmepsin 2 and 3 genes (Dall, 2018). The combination of these markers is found in the 
parasites with increased biological fitness that are primarily responsible for the spread of this 
crisis (Dall, 2018). 
This emergent strain threatens to hinder recent progress made in global malaria control 
efforts; according to the WHO, “malaria deaths in the [southeast Asian] region have declined by 
44%” since 2010 (Dall, 2018). Much of this success was dependent on ACT; as a result, 
increasing ACT resistance does not bode well (Dall, 2018). Of particular concern is the 
possibility of the artemisinin-resistant strain spreading to Africa, “which accounts for 90% of 
malaria cases” (Dall, 2018). Resolution of this issue may prove complicated; some believe ACT 
can continue to be effective under strict management of dihydroartemisinin-piperaquine and 
introduction of artesunate-mefloquine, which is another variation of ACT (Dall, 2018). However, 
the concern is that history will repeat itself, with the parasite becoming resistant to new therapies 
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and rendering them ineffectual as well (Dall, 2018). Many scientists advocate for greater genetic 
surveillance in order to better monitor malarial mutation and improve response time (Dall, 2018). 
Tuberculosis 
Since TB is caused by bacteria, treatment failure in this case falls into the category of 
antibiotic resistance (“Antibiotic-Resistant Mycobacterium…”, 2012). There are two types of 
resistant TB that are creating challenges (“Antibiotic-Resistant Mycobacterium…”, 2012). The 
most common variety is multidrug-resistant tuberculosis (MDR TB); the TB bacteria in this form 
are unresponsive to treatment by at least one first-line anti-TB drug and cannot be killed by 
either isoniazid (INH) or rifampin (RIF), which are the two antibiotics most commonly used in 
therapy (“Antibiotic-Resistant Mycobacterium…”, 2012). Treatment of MDR TB is therefore 
more complicated and involves up to two years of multidrug administration, involving second-
line drugs (“Antibiotic-Resistant Mycobacterium…”, 2012). Another, much more rare type of 
TB is extensively drug-resistant TB (XDR TB), which is “is resistant to isoniazid and rifampin, 
plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, 
kanamycin, or capreomycin)” (“Treatment for TB Disease”, 2016). This is therefore, the most 
challenging to treat (“Antibiotic-Resistant Mycobacterium…”, 2012). 
Antibiotic resistance occurs when bacteria change in their response to antibiotic 
medications. Even when resistant bacteria could be killed or inhibited by a sufficiently high 
concentration of medication, that large of a dose would ultimately prove harmful to the patient 
(Hawkey, 1998). Clinical resistance is characterized by the interaction of “the type of infecting 
bacterium, its location in the body, the distribution of the antibiotic in the body and its 
concentration at the site of infection, and the immune status of the patient” (Hawkey, 1998). 
There are also four main mechanisms by which resistance can arise (Hawkey, 1998). First, the 
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most well-known mechanism is that of antibiotic modification; this occurs when the antibiotic is 
prevented from reaching its target, although the target remains as sensitive as it would in a 
normal strain (Hawkey, 1998). Second, the resistant bacteria can protect the target by blocking 
the antibiotic’s entrance to the cell or “pumping it out faster than it can flow in” (Hawkey, 1998). 
Another mechanism involves the alteration of the primary site of action (Hawkey, 1998). This 
means that, although the antibiotic is able to enter the cell and reach the target site, it cannot 
generate any action due to structural changes in the molecule (Hawkey, 1998). The final way by 
which bacteria can resist treatment is via the creation “of an alternative target (usually an 
enzyme) that is resistant to inhibition by the antibiotic while continuing to produce the original 
sensitive target” (Hawkey, 1998). 
In 2017, the European Respiratory Journal reported that there are “an estimated 480 ,000 
new cases [of MDR-TB] emerging globally each year” (Chee et al., 2017). Drug-resistant 
tuberculosis primarily occurs as a result of drug misuse or mismanagement (“What is 
multidrug…”, 2018). This can include circumstances where healthcare providers make mistakes 
concerning the treatment, duration of treatment, or dosage, patients do not finish the entire 
course of treatment, or when the proper quality or supply of medication is lacking (“What is 
multidrug…”, 2018). MDR-TB is therefore more common in areas, such as developing 
countries, where regulation of TB treatment is insufficient (Zaman, 2010). As discussed above, 
the rural nature of much of Cambodia’s healthcare hinders surveillance endeavors and the rapid 
identification of cases (Zaman, 2010). 
Rural Healthcare Challenges  
 As compared to metropolitan and urban environments, ‘rurality’ “reflects smaller 
populations, and distance and isolation from major centres with a corresponding lack of access to 
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the full range of services and infrastructure”; healthcare in these areas is different in 
demographic, geographic, and sociological settings (Paliadelis, Parmenter, Parker, Giles, & 
Higgins, 2017). Even in developed countries, rural healthcare presents challenges both for 
physicians and patients (Paliadelis et al., 2017). Any existing healthcare professionals in remote 
regions must possess a wider variety of skills, due to the lack of available specialists (Paliadelis 
et al., 2017). Oftentimes physicians in isolation have minimal access to professional 
development, peer support, and supervision (Paliadelis et al., 2017). These circumstances place 
enormous pressure on professionals and can limit the amount knowledge they are able to acquire 
(Paliadelis et al., 2017). Other challenges, some of which have already been highlighted in brief, 
include limited access to specialized treatments and diagnostic equipment, as well as inadequate 
facilities, if they even exist at all (Ryan, 2004). Another point of concern is the economic burden 
caused when patients are required to travel great distances for treatment (Ryan, 2004).  
Ultimately, rural areas in Cambodia are lacking in the detection and reporting of several 
diseases, including malaria and tuberculosis; this inability to quickly and accurately diagnose 
patients is a major factor contributing to the AMR phenomenon (Zaman, 2010). Increased access 
to diagnostic tools, including rapid test kits, can help affected individuals receive treatment more 
promptly (“Malaria: Asia Regional”, 2019). Even so, ineffectual or nonexistent equipment is 
only one part of the problem; even if communities are supplied with the proper tools, there must 
be individuals trained to use them and provide comprehensive care. 
When attempting to develop solutions for the difficulties faced by rural communities, 
there are a number of challenges that must be considered (Ryan, 2004). First of all, not everyone 
agrees on what ‘adequate’ healthcare access entails and which services are most important 
(Ryan, 2004). Additionally, urban models do not always translate well to rural communities; 
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there can exist a “tendency to direct strategies towards alleviation of symptoms as opposed to 
elimination of etiologies” and ultimately miss the fundamental causes of the health deficit (Ryan, 
2004). The sustainability of healthcare in remote areas is of particular concern. (Ryan, 2004). 
Avenues of Aid 
 As seen in the above section, multiple factors have to be considered when possible 
solutions are being discussed. The manner in which aid is provided can almost be as important as 
the aid itself. Several organizations and governments are currently offering assistance to 
Cambodia through a variety of avenues. Both national and foreign efforts have been made to 
strengthen rural healthcare. 
Empowering Local Volunteers 
One way that rural communities can be better supported and integrated into the ‘fold’ of 
Cambodian healthcare is by better equipping national volunteers (Ozano, Simkhada, Thann, & 
Khatri, 2018). In recent years, Cambodia created the ‘Community Participation Policy for 
Health’, which led to the creation of community health workers; the policy dictated that “CHWs 
should be literate, live in the communities they serve and be elected by community members” 
(Ozano et al., 2018). CHWs are responsible for about 10 to 50 households, depending on the 
community and are trained at and supervised by a national health center (Ozano et al., 2018). 
These national volunteers are integral components of connecting rural communities to public 
health systems (Ozano et al., 2018). Many national and international non-government 
organizations (NGOs) contribute to the financing of this initiative (Ozano et al., 2018).  
CHWs serve as front-line caregivers in under-served regions, but they have experienced 
numerous challenges that limit the care they could be providing (Ozano et al., 2018). Many of 
the CHMs are close to the poverty line and risk reduction of income as a result of their volunteer 
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work (Ozano et al., 2018). The main issues include a lack of support and leadership from the 
local government, inadequate resources, and inconsistent training programs; additionally, the 
CHWs are pulled in many directions due to a mixture of external foreign influences (Ozano et 
al., 2018). Increased dependency on international support raises a concern as to the sustainability 
of this program in the future, due to the partners’ geographic and resource limitations (Ozano et 
al., 2018). CHWs need “a more structured delivery system that allows them to be part of the 
planning and development process”, as well as more tools and comprehensive training (Ozano et 
al., 2018). 
The Complexity of Short-Term Missions 
 In addition to the niche filled by national support, foreign aid has a big role to play (Chiu, 
Weng, Chen, Yang, & Lee, 2012). Short-term medical missions (STMMs) primarily target rural 
and underprivileged areas and offer health care to those without access to any developed system 
(Chiu et al., 2012). The primary goal of most of these trips is to lift the burden of disease 
associated with physician shortages and meet unmet needs (Sykes, 2014). They are typically 
organized from high-income countries (HICs) to low- and middle-income countries (LMICs) and 
have risen in frequency with increased globalization (Sykes, 2014). STMMs can be defined as 
“trips in which volunteer medical providers from HICs travel to LMICs to provide health care 
over periods ranging from 1 day to 8 weeks” and can be associated with either faith-based or 
non-faith-based organizations (Sykes, 2014). 
STMMs face a variety of challenges including “a lack of follow-up care, short duration, 
too many patients, language and cultural barriers, limited medications and supplies, and a lack of 
support services from local authorities” (Chiu et al., 2012). These mission trips are not part of 
any standardized system, which is a cause of concern (Sykes, 2014). Very little empirical data 
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exists concerning the results of these projects and some fear unintended consequences, including 
lax drug accountability (Johnson, 2017). Despite the best intentions of the outreach, “service 
trips can often become self-serving for the institution and ineffective, inappropriate, or 
burdensome to the existing health care infrastructure and to the local population” (Johnson, 
2017). Respectful and effective communication with the local community is a key component to 
successful STMMs is (Johnson, 2017). A good relationship with the national community will 
ensure the team understands the community’s priorities and is working within any preexisting 
infrastructure, so as to not undermine local care (Johnson, 2017). 
Conclusion  
 Cambodia is a beautiful nation, characterized by a warm and vibrant people grounded in 
a proud and long-enduring culture. Its position in the Greater Mekong Subregion places it in the 
beating heart of Southeast Asia. Once a prospering and thriving market for trade, modern history 
has seen a large part of this region rocked by a series of devastating events. The horrific genocide 
committed by the Khmer Rouge under the leadership of Pol Pot set Cambodia back in a 
significant number of areas. Of particular concern is how it affected the country’s healthcare 
system; Cambodia experienced a crippling loss of facilities and trained personnel. Although the 
nation’s capital of Phnom Penh and its more metropolitan areas have made remarkable progress 
on the road to recovery, the majority of Cambodian people live in rural communities that lack 
sufficient healthcare.  
 This rural disparity has amplified many of the issues the region is already dealing with. 
Malaria, tuberculosis, and HIV have been three of the worst and most lethal diseases, both in 
Cambodia and throughout the Greater Mekong area. There has been significant success achieved 
in combatting these issues, but antimicrobial resistant varieties threaten to halt and undermine the 
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work that has already been done. Without the proper tools, diagnoses are often not made soon 
enough and resistant strains spread quickly; the lack of effective equipment and adequate 
medical supplies and professionals have made treatment extremely difficult.  
In attempting to rectify and alleviate many of the unique challenges faced by rural 
regions, much concern has arisen as to how ‘solutions’ are being enacted. Many avenues exist by 
which aid can be offered, but each one possesses its own complexities and complications. 
National efforts must be supported in their endeavors to provide healthcare. CHW are a 
promising step forward in decreasing the rural disparity, but the current system is far from 
perfect. Foreign medical aid is a powerful tool that brings quality care to places that would never 
have access to comprehensive modern medicine otherwise. However, there are ethical 
components that require careful analysis. A healthy Cambodia could help its fellow Southeast 
Asian nations in their own endeavors to combat disease and institute widespread quality medical 
care.   
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